Cargando…

Blood-Based Immune Protein Markers of Disease Progression in Murine Models of Acute and Chronic Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a chronic ailment afflicting millions of people worldwide, with the majority of recognized cases within industrialized countries. The impacts of IBD at the individual level are long-lasting with few effective treatments available, resulting in a large burden on th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Renner, Tyler Milston, Agbayani, Gerard, Dudani, Renu, McCluskie, Michael J., Akache, Bassel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9855888/ https://www.ncbi.nlm.nih.gov/pubmed/36672648 http://dx.doi.org/10.3390/biomedicines11010140

Ejemplares similares

Simplified Admix Archaeal Glycolipid Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Enhances Protection from Murine Melanoma
por: Stark, Felicity C., et al.
Publicado: (2019)

The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combined with Different Adjuvants in a Murine Model
por: Jia, Yimei, et al.
Publicado: (2021)

Evaluation of Adjuvant Activity and Bio-Distribution of Archaeosomes Prepared Using Microfluidic Technology
por: Jia, Yimei, et al.
Publicado: (2022)

Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice
por: Akache, Bassel, et al.
Publicado: (2018)

Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model
por: Akache, Bassel, et al.
Publicado: (2021)

Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine Formulations Targeting Rabbit Hemorrhagic Disease Virus Are Immunogenic and Efficacious
por: Akache, Bassel, et al.
Publicado: (2023)

Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters
por: Stark, Felicity C., et al.
Publicado: (2022)

Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations
por: Agbayani, Gerard, et al.
Publicado: (2020)

An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma
por: Stark, Felicity C., et al.
Publicado: (2017)

Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern
por: Akache, Bassel, et al.
Publicado: (2022)

Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern
por: Renner, Tyler M., et al.
Publicado: (2023)

Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant
por: Akache, Bassel, et al.
Publicado: (2021)

Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins
por: Akache, Bassel, et al.
Publicado: (2019)

Preclinical evaluation of manufacturable SARS-CoV-2 spike virus-like particles produced in Chinese Hamster Ovary cells
por: Alpuche-Lazcano, Sergio P., et al.
Publicado: (2023)

Anti-IgE Qb-VLP Conjugate Vaccine Self-Adjuvants through Activation of TLR7
por: Akache, Bassel, et al.
Publicado: (2016)

Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both
por: Beitari, Saina, et al.
Publicado: (2023)

Dissociation by steroids of eosinophilic inflammation from airway hyperresponsiveness in murine airways
por: Birrell, Mark A, et al.
Publicado: (2003)

Ringbodies in Anæmia
por: Monro, T. K., et al.
Publicado: (1925)

Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity
por: McCluskie, Michael J., et al.
Publicado: (2017)

Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice
por: Maltseva, Mariam, et al.
Publicado: (2022)

Serological markers of inflammatory bowel disease
por: Kuna, Andrea Tešija
Publicado: (2013)

Homologous Prime-Boost Vaccination with OVA Entrapped in Self-Adjuvanting Archaeosomes Induces High Numbers of OVA-Specific CD8(+) T Cells that Protect Against Subcutaneous B16-OVA Melanoma
por: Stark, Felicity C., et al.
Publicado: (2016)

Biological markers of disease activity in inflammatory bowel diseases
por: Szymanska, Edyta, et al.
Publicado: (2023)

Diagnostic Markers for Nonspecific Inflammatory Bowel Diseases
por: Derkacz, Alicja, et al.
Publicado: (2018)

Combined Use of Common Fecal and Blood Markers for Detection of Endoscopically Active Inflammatory Bowel Disease
por: Mak, Lung-Yi, et al.
Publicado: (2020)

Inflammatory Bowel Disease: A Review of Pre-Clinical Murine Models of Human Disease
por: Katsandegwaza, Brunette, et al.
Publicado: (2022)

Evaluation of Early Atherosclerosis Markers in Patients with Inflammatory Bowel Disease
por: Üstün, Yusuf, et al.
Publicado: (2016)

The Value of Fecal Markers in Predicting Relapse in Inflammatory Bowel Diseases
por: Galgut, Bianca J., et al.
Publicado: (2018)

Oxidative Stress Markers in Inflammatory Bowel Diseases: Systematic Review
por: Krzystek-Korpacka, Małgorzata, et al.
Publicado: (2020)

Inflammatory Bowel Disease and Pregnancy: Is It a Marker for Adverse Outcomes?
por: Costa, Rita Vicente, et al.
Publicado: (2022)

Inflammatory and Lipid-Associated Markers of Cardiovascular Diseases in Children with First Exacerbation of Inflammatory Bowel Disease
por: Pac-Kożuchowska, Elżbieta, et al.
Publicado: (2016)

Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease
por: Lord, James D., et al.
Publicado: (2015)

The effect of vitamin D administration on inflammatory markers in patients with inflammatory bowel disease
por: Jun, Jae Chang, et al.
Publicado: (2019)

Helminth Lessons in Inflammatory Bowel Diseases (IBD)
por: Atagozli, Tyler, et al.
Publicado: (2023)

Precision medicine in inflammatory bowel disease: concept, progress and challenges
por: Borg-Bartolo, Simon P., et al.
Publicado: (2020)

Reproduction and Growth in a Murine Model of Early Life-Onset Inflammatory Bowel Disease
por: Nagy, Eniko, et al.
Publicado: (2016)

Inflammatory Markers and COVID-19 Disease Progression
por: Sidhwani, Santosh Kumar, et al.
Publicado: (2023)

Functional Food Components, Intestinal Permeability and Inflammatory Markers in Patients with Inflammatory Bowel Disease
por: Lacerda, Joana Franco, et al.
Publicado: (2021)

Investigation of potential early Histologic markers of pediatric inflammatory bowel disease
por: Bass, Julie A., et al.
Publicado: (2015)

Evaluation of novel serological markers and autoantibodies in dogs with inflammatory bowel disease
por: Estruch, Juan J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vf797d863j8gf6222ehmsthu3g